CME Information | ASCRS
ASCRS Grand Rounds

CME Information

ASCRS gratefully acknowledges the unrestricted educational grants received in support of this program from:
Allergan
Bausch + Lomb
CorneaGen
EyePoint Pharmaceuticals Inc.
Glaukos
Johnson & Johnson Vision
Kala Pharmaceuticals, Inc.
New World Medical
Sun Pharmaceutical Industries, Ltd.
Zeiss

ACCME Accredited

Accreditation Statement

The American Society of Cataract and Refractive Surgery is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. ASCRS takes responsibility for the content, quality and scientific integrity of the CME activity.

Designation Statement

The American Society of Cataract and Refractive Surgery designates Grand Rounds within this online educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

All CME activities approved for AMA PRA Category 1 Credits™ are valid for recognition by the European Accreditation Council for Continuing Medical Education (EACCME). Physicians not licensed in the U.S. who participate in this CME activity are eligible for AMA PRA Category 1 Credits™.

Target Audience

This educational activity is intended for a broad audience to include ophthalmic residents, fellows, and surgeons in practice.

Educational Objectives

Ophthalmologists attending this program should be able to:

  • Develop a diverse differential diagnosis
  • Improve surgical and decision-making skills
  • Implement strategies to manage complications
  • Compare and contrast ophthalmic treatments and technology
  • Review established practice patterns from experts

Notice About Off-Label Use Presentations

The ASCRS Annual Meeting may include presentations on drugs or devices or uses of drugs or devices that may not have been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice. ASCRS is committed to the free exchange of medical education. Inclusion of any presentation in this program, including presentations of off-label uses, does not imply an endorsement by ASCRS of the uses, products or techniques presented.

We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Privacy Policy and Legal Notice.